Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
A PHASE2/PHASE3 clinical study on Cirrhosis and Refractory/Recurrent Ascites, this trial is completed. The trial is conducted by Post Graduate Institute of Medical Education and Research, Chandigarh and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Jul 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Apr 2024 [monthly]
Completed PHASE2_PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE2_PHASE3
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Post Graduate Institute of Medical Education and Research, Chandigarh
For direct contact, visit the study record on ClinicalTrials.gov .